Member Info for beinthelead

Not obsessed Tom. At all.

Why go mute right now? I’m fascinated. Timing is odd, that’s what I’m saying.

Most of what you’ve tweeted on the rise from 50-140 was not new, yet you repeated quotes relentlessly for weeks. Now just stop? When the other cheer leaders stop? Not odd to you?

Your cheerleading follows the exact pattern you exhibited on ODX.

Wres’s Twitter: https://twitter.com/to_aquis/status/1537702760589713408?s=20&t=De4GSPFrmJAX67LzC1G8Zw

Convinced he’s been here a while and supporter of TW. Report. Block. And hope they disappear.

And some people on here had the idiocy to Rex and humour this fool while he was ramping. Kind of epitomises the swings in mood.

You wuss. I’m not topping up til at least 38p.

It doesn’t take much, does it. Still amazes me how quickly the mood music flips, even thought it shouldn’t. How many times have we been here.

Tom has taken some time of Twitter. The others have just left. At exactly the same time this attack happens? Odd.

Literally nothing has changed in the last week other than outside influences (market forces).

Data can’t come soon enough to put this whole thing to bed.

Twitter gang is very quiet. Is ‘little gunner’ on here? He’s a rather odd cheer leader.

Wyn needs to receive a ban.

This stock is cyclic.

Ramp cycle:

We’ve a month or so of mega ramping on Twitter, led by the same users. All repeating the same old news and ambiguous ‘it works’. Even deleting tweets now. The platform has been quiet for a couple of days.

Short cycle:

TW has declared a short interest and we’re now seeing panic selling/short positions taken. Twitter ramp gang is quiet. The BB is now imploding with disruptive nonsense from Wyn et al. Troll of the highest order. Expect new accounts on here and Twitter.

Like the above cycles, the SP will wave a bit until news.

PL - I’m literally fed up with your reasoned logic. It’s too balanced. Too likely-correct.

These ‘it works’ links are getting ridiculous.

Bored? We’ll resemble the crypt keeper by the time we see this bl00dy data.

You already had a bot thread for this. Makes no sense.

It’s difficult to read across from those take overs. Especially the gilead deal. It serves to blind PI’s from the risk, IMO.

“The only thing I’m sure of is 90% of current holders will have bailed long beyond that time.”

I disagree. This a popular stock with no proven foundations at present. Prove this tech works in a few weeks time, and people will gladly hold. Ie, they believe it ‘works’ now (we don’t know) - imagine if/when we find out it does.

AGL is a totally different beast. They’re only compared due to their respect market and a clutch of influential joint holders. Avacta is looking to prove a platform with unfathomable application.

Let’s wait a while for the buy out. Data and licensing will be worth a couple of £Bn. We’ll know soon enough.

We e had a consistent seller for over 2 years that I know of. It’s literally meaningless. Granted, people don’t focus on sells, just buys.

Why would you sell so close to results??? People need the money. Traders. New houses. New cars. Timster needs a new calendar as he’s consistently confused as the when ASCO happens.

Is it a slight on my character that I found this funny?? :)

Yeah, yeah. Next you’ll be telling me there’s an AGM.

Codejunkie - look back over the RNS’s. We’ve been waiting years for them. I choose to forget the whole thing as it makes my spider sense tingle when I hear AS speak. The Dx speech’s are legendary - all absolutely rhubarb.

Tx should be a different story.

SureScreen have the market seen up. Good luck to them. Our USP was our agility and the superiority of our tech. Neither one being proven. Rip’s right; AS confirmed preg style stuff is bagged.

What are they Codejunkie?

The accounts literally tell us it’s a money pit. No revenue, massive outlay. Albeit a lot of one off costs.

For the size and appetite of the biz were still waiting for Vit D etc. years waiting. The LFT has been gracefully brushed until data makes it redundant. 6 months to Affimer-ize the test? Not a good if we were actually banking on it.

Forget the Dx biz.

It’s a PR thing. And hopefully a sign that they think therapeutics can carry it in the short term. Stripping the biz part way through a risky trial is not a good strategy.

AVA works, we’ll see the biz sold off. It’s a waste of money.

It’s a new e-commerce website.